Kathleen Moore, MD

Articles by Kathleen Moore, MD

Kathleen Moore, MD, director of the Oklahoma TSET Phase I Program and an associate professor of the Section of Gynecologic Oncology at The University of Oklahoma College of Medicine

Kathleen Moore, MD, on the Key Takeaways of 3 Clinical Trials Examining Niraparib in BRCA-Mutant Ovarian Cancer

ByKathleen Moore, MD

June 27th 2021

Kathleen Moore, MD, discusses findings compiled from 3 clinical trials of niraparib in patients with ovarian cancer.

Latest Updated Articles

Kathleen Moore, MD, on the Key Takeaways of 3 Clinical Trials Examining Niraparib in BRCA-Mutant Ovarian Cancer
June 27th 2021

Trending on CancerNetwork

FDA Approves Perioperative Durvalumab/Enfortumab Vedotin in MIBC

Subsequent Therapy May Have Narrowed the Overall Survival Gap in LITESPARK-011

Managing Emergencies During Outpatient Bispecific Step-Up Dosing

ACS Updates Prostate Cancer Screening Guideline With Risk-Based PSA Intervals

Why Caregivers Are Critical During Bispecific Step-Up Dosing